To cite this paper use one of the standards below:
Schistosomiasis is chronic parasitic disease caused by trematodes of the genus Schistosoma, it’s commonly caused by S. mansoni. Studies show that more than 200 million people are infected and more than 90% of them live in Africa. Treatment with praziquantel has the best cost-benefit of the market. However, hypersensitivity reaction, allergy and drug resistance are frequently presented after administration. In this perspective, ligand-based and structure-based virtual screening (VS) techniques were combined to select potentially active alkaloids against S. mansoni from an internal dataset (SistematX). A set of molecules with known activity against S. mansoni was selected from the ChEMBL database to create two different models with accuracy greater than 84%, enabling the ligand-based VS of the alkaloid bank. Subsequently, structure-based VS was performed through molecular docking using five targets of the parasite. Finally, a consensus analysis was performed combining the VS techniques and five alkaloids with schistosomicidal potential were selected.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper